(2026). Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study. ImmunoTargets and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Targeting BLyS and APRIL with Telitacicept Versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study."
ImmunoTargets and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Targeting BLyS and APRIL with Telitacicept Versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study."
ImmunoTargets and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.